Overview of ICH E2F – Development SafetyDevelopment …

Overview of ICH E2F – Development SafetyDevelopment Safety Update Report (DSUR) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use

  International, Development, Report, Update, Safety, Conference, International conference on harmonisation, Harmonisation, Safetydevelopment, Ich e2f, Ich e2f development safetydevelopment safety update report

Guideline on good pharmacovigilance practices (GVP)

Clinical trial 92 Any investigation in human subjects intended to discover or verify the clinical, pharmacological and/or 93 other pharmacodynamic effects of one or more investigationa l medicinal product(s), and/or to identify

  Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance

DEVELOPMENT SAFETY UPDATE REPORT - ICH

The Development Safety Update Report (DSUR) proposed in this guideline is intended to be a common standard for periodic reporting on drugs under development (including

  Development, Report, Update, Safety, Development safety update report

平成24年12月28日 - jmacct.med.or.jp

1．改正省令による改正後の規則第273条第3項について 治験の依頼をした者（以下「治験依頼者」という。

Drug Development 1.2 Procedures for Clinical Trials

37 Basic standards for periodically reporting safety information during the development phase, common to all drugs, etc., are available in “Development Safety Update

  Clinical, Procedures, Trail, Procedures for clinical trials